CRY News and Press, CryoLife Inc. From 08/31/21

CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire ATLANTA , Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that i...

The following slide deck was published by CryoLife, Inc. in conjunction with this event. For further details see: Cryolife (CRY) Investor Presentatio - Slideshow

Image source: The Motley Fool. Cryolife Inc (NYSE: CRY) Q2 2021 Earnings Call Jul 29, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cryolife Inc (CRY) Q2 2021 Earnings Call Transcript

CryoLife Reports Second Quarter 2021 Financial Results PR Newswire ATLANTA , July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $5...

CryoLife Announces Sale of PerClot to Baxter PR Newswire ATLANTA , July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerCl...

CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results PR Newswire ATLANTA , July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, ann...

Inflation is here; and that means these groups ought to be on your radar. The best stocks within every sector now. Over 20 new stocks join our 'best stocks' list this week. For further details see: The Stocks To Focus On Today

Market leadership by sector and market cap. Sectors remain tilted toward mid-cycle ideas. However, stock-specific ideas are available in every basket. For further details see: The Top Stocks You Can Buy Now

CryoLife to Participate in the UBS Global Healthcare Virtual Conference PR Newswire ATLANTA , May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will part...

CryoLife continues to perform on recent fundamental and technical momentum, where shareholders have enjoyed +25% upside YTD. The company is well positioned to benefit from market crosscurrents in global supply chain logistics and growth in key end-markets in FY2021. Product sales ...